FEMTOBIOMED
Femtobiomed is a research and delivery platform for the development of anti-cancer treatment drugs.
FEMTOBIOMED
Social Links:
Industry:
Biopharma Biotechnology Medical Nanotechnology
Founded:
2011-07-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.femtobiomed.com
Total Employee:
11+
Status:
Active
Contact:
(+82) 031-622-8501
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business PHP Google GStatic Google Static Content
Similar Organizations
Inventage lab
Inventory Lab is a Next-generation drug delivery platform using innovative manufacturing method.
Official Site Inspections
http://www.femtobiomed.com Semrush global rank: 6.94 M Semrush visits lastest month: 682
- Host name: 183.111.169.45
- IP address: 183.111.169.45
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Femtobiomed"
FEMTOBIOMED
Compatible with Femtobiomed CellShot WSC(Wide-scale Cartridge) Release Date - 2023.06. SSC-111. Cartridge specification. Processed volume (mL) : 0.33; Processed cell volume (10 6 …See details»
Femtobiomed Inc. - LinkedIn
Femtobiomed is a cell engineering device manufacturing company built upon CellShot®, employing the patented ‘Partitioned Flow Transfection’.See details»
Femtobiomed - Crunchbase Company Profile & Funding
Femtobiomed is funded by ActnerLab. When was the last funding round for Femtobiomed? Femtobiomed closed its last funding round on Jan 1, 2015 from a Venture - Series Unknown …See details»
Femtobiomed Inc. Overview | SignalHire Company Profile
Femtobiomed is a cell engineering device manufacturing company built upon CellShot®, employing the patented ‘Partitioned Flow Transfection’. ... Using a multiple port cartridge, the …See details»
FEMTOBIOMED Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for FEMTOBIOMED Inc. of Seongnam, Gyeonggi. Get the latest business insights from Dun & …See details»
Femtobiomed Inc. (XKON: 327610) Company Profile & Overview
Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its …See details»
Company Femtobiomed Inc. - MarketScreener.com
Sep 13, 2024 Company Femtobiomed Inc. Equities A327610 KR7327610002 Biotechnology & Medical Research End-of-day quote Korea S.E. Other stock markets. 2024-09-13 5-day …See details»
Femtobiomed Company Profile 2024: Stock Performance
What industry is Femtobiomed in? Femtobiomed’s primary industry is Biotechnology. Is Femtobiomed a private or public company? Femtobiomed is a Public company. What is …See details»
Femtobiomed Inc - Company Profile and News - Bloomberg Markets
Company profile page for Femtobiomed Inc including stock price, company news, executives, board members, and contact informationSee details»
Femtobiomed - Tech Stack, Apps, Patents & Trademarks
Femtobiomed is a research and delivery platform for the development of anti-cancer treatment drugs.See details»
Femtobiomed - Products, Competitors, Financials, Employees ...
Femtobiomed's technology primarily serves the biomedical research and clinical therapy industries, providing tools to improve the delivery and efficacy of cell-based treatments. It was …See details»
Femtobiomed - Funding, Financials, Valuation & Investors
Jan 1, 2015 Femtobiomed is a research and delivery platform for the development of anti-cancer treatment drugs. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How …See details»
Femtobiomed Inc. on LinkedIn: #isscr2023 #stemcellresearch # ...
FemtoBioMed Completes FDA Master File for CELLSHOT® Badger Device! ... and field application within the Biopharma and Life Science sectors, Chang brings a wealth of expertise …See details»
About Femtobiomed Inc (327610) - Investing.com
Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines.See details»
Nanoinjection system for precise direct delivery of biomolecules …
Feb 12, 2019 4 Femtobiomed Inc., Seongnam, 13487, Republic of Korea. [email protected]. 5 Paean Biotechnology Inc., Daejeon, 34028, Republic of Korea. …See details»
327610 Stock Price Quote | Morningstar
Oct 10, 2024 See the latest Femtobiomed Inc Ordinary Shares stock price (327610:XKRX), related news, valuation, dividends and more to help you make your investing decisions.See details»
SmartDrop - Crunchbase Company Profile & Funding
Organization. SmartDrop . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone …See details»
Femtobiomed, Inc. (Femtobiomed, Inc.) - 药物管线_专利_临床试 …
了解Femtobiomed, Inc. (Femtobiomed, Inc.)公司的药物管线，治疗领域，技术平台，以及它的3篇新闻和1篇文献，疾病领域:肿瘤，技术平台:治疗性疫苗，药物:B-cell based antigen vaccine …See details»
B-cell based antigen vaccine (Femtobiomed) - Drug Targets
Abstract Purpose: A multicenter, randomized, open-label, phase II study (HERIZON; NCT02795988) was conducted to evaluate the clinical and immunologic efficacy of HER-Vaxx …See details»
B-cell based antigen vaccine - Femtobiomed - AdisInsight - Springer
Nov 28, 2023 21 Oct 2019 Femtobiomed files for patent protection for Cell Shot delivery technology in South Korea (Femtobiomed company website, October 2019) You need to be a …See details»